GFRα3 Protein - GDNF Family Receptor Alpha 3

GFRα3 Protein - GDNF Family Receptor Alpha 3

Introduction

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">GFRα3 Protein - GDNF Family Receptor Alpha 3</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>GFRA3</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>4p15.2</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>64054</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9Y5R5</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000146070</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~45-50 kDa (pre-pro form)</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>465 amino acids</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

Gfrα3 Protein Gdnf Family Receptor Alpha 3 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

GFRα3 Protein - GDNF Family Receptor Alpha 3

Introduction

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">GFRα3 Protein - GDNF Family Receptor Alpha 3</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>GFRA3</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>4p15.2</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>64054</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9Y5R5</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000146070</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~45-50 kDa (pre-pro form)</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>465 amino acids</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

Gfrα3 Protein Gdnf Family Receptor Alpha 3 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

GFRα3 (GDNF Family Receptor Alpha 3) is a glycosylphosphatidylinositol (GPI)-anchored cell surface receptor that serves as the primary high-affinity receptor for the neurotrophic factor artemin (ARTN). Part of the GDNF family receptor alpha (GFRα) protein family, GFRα3 plays essential roles in the development, survival, and maintenance of specific neuronal populations in the peripheral nervous system. While primarily studied in the context of sensory and sympathetic neuron biology, emerging research suggests potential roles in central nervous system function and disease contexts including neurodegenerative processes. [@artemin]

The GFRα3/RET signaling complex mediates potent neurotrophic effects that promote neuronal survival, axonal growth, and phenotypic maintenance. This receptor system represents an important therapeutic target for conditions involving peripheral neuron dysfunction, chronic pain, and potentially neurodegenerative diseases affecting sensory pathways. [@neurotrophic]

Gene and Protein Structure

Gene Information

The GFRA3 gene is located on chromosome 4p15.2 and encodes the GFRα3 protein. The gene structure consists of multiple exons spanning approximately 14 kb of genomic DNA. Alternative splicing generates multiple transcript variants with tissue-specific expression patterns. [@growth]

Protein Domain Architecture

GFRα3 possesses the characteristic domain structure of the GFRα receptor family:

• Signal peptide (1-21 aa): N-terminal signal sequence for cotranslational insertion into the endoplasmic reticulum
• N-terminal domain: Contains the ligand-binding interface
• Three cysteine-rich domains (CRDs): Each CRD contains conserved cysteine residues forming disulfide bonds that create the structural framework for artemin binding
• GPI anchor signal sequence (C-terminus): Directs post-translational attachment of the GPI moiety, anchoring the protein to the outer leaflet of the plasma membrane

Normal Function

Ligand Binding and Receptor Complex Formation

GFRα3 exhibits exceptional specificity for artemin, with a dissociation constant (Kd) in the low picomolar range (~10 pM). The binding mechanism involves:

Signaling Pathways

RET-Dependent Signaling

When GFRα3 complexes with RET, it activates multiple signaling pathways:

• PI3K/Akt pathway: Promotes cell survival through phosphorylation and inactivation of pro-apoptotic proteins including BAD, caspase-9, and FoxO transcription factors
• Ras/Raf/MEK/ERK pathway: Stimulates neuronal differentiation, axonal growth, and gene expression
• PLCγ pathway: Modulates calcium signaling and protein kinase C activation

RET-Independent Signaling

GFRα3 can also signal independently of RET through interactions with other membrane proteins:

• NCAM (Neural Cell Adhesion Molecule): GFRα3 can bind to NCAM, activating Src family kinases and promoting neuronal survival
• Integrin interactions: May influence cell adhesion and migration through integrin-mediated pathways

Tissue Distribution

GFRα3 expression is predominantly peripheral but extends to some central nervous system regions:

• Sensory [neurons](/entities/neurons): Dorsal root ganglion (DRG) neurons, particularly small-diameter nociceptors
• Sympathetic neurons: Superior cervical ganglion and other sympathetic ganglia
• Enteric nervous system: Subset of enteric neurons
• Peripheral tissues: Low expression in some non-neuronal tissues including kidney, lung, and testis
• Central nervous system: Limited expression in specific brain regions including thalamus and hypothalamus

Physiological Roles

Sensory Neuron Development and Maintenance

• Developmental survival: Artemin/GFRα survival of sensory neuron precursors during development
• Ax3 signaling promotesonal guidance: Provides tropic support for extending axons toward target tissues
• Phenotype maintenance: Maintains neuronal phenotype and function in adulthood
• Nociceptor function: Regulates sensitivity and survival of pain-sensing neurons

Sympathetic Nervous System

• Neuronal survival: Supports sympathetic neuron survival during development
• Target innervation: Guides axons to appropriate target fields
• Postnatal maintenance: Maintains sympathetic neuron function

Pain Modulation

The artemin/GFRα3 system has complex effects on pain processing:

• Nociceptor sensitization: Artemin can sensitize nociceptors to thermal and mechanical stimuli
• Analgesic potential: However, systemically administered artemin has shown analgesic effects in chronic pain models
• Neuropathic pain: GFRα3 signaling may promote regeneration of damaged sensory fibers

Role in Disease

Peripheral Neuropathy

Chemotherapy-Induced Neuropathy

The artemin/GFRα3 system has been investigated for chemotherapy-induced peripheral neuropathy (CIPN):

• Neuronal protection: Artemin administration protects sensory neurons from chemotherapy-induced death
• Axonal regeneration: Promotes regeneration of damaged nerve fibers
• Functional recovery: Improves sensory function in animal models of CIPN
• Therapeutic potential: Recombinant artemin and GFRα3 agonists are being explored as treatments

Diabetic Neuropathy

• Metabolic stress response: GFRα3 signaling may protect against metabolic dysfunction in diabetic neuropathy
• Neuronal survival: Supports sensory neuron viability under hyperglycemic conditions
• Therapeutic exploration: Artemin-based therapies have been investigated

Chronic Pain Disorders

The role of GFRα3 in pain is context-dependent:

• Inflammatory pain: Artemin/GFRα3 can contribute to inflammatory pain hypersensitivity
• Neuropathic pain: May promote nerve regeneration and recovery from neuropathic injury
• Cancer pain: GFRα3 expression in tumor cells may influence cancer-related pain

Neurodegenerative Disease Connections

While primarily a peripheral receptor, GFRα3 has potential connections to neurodegenerative processes:

Alzheimer's Disease

• Peripheral neuropathy in AD: Patients with AD may develop peripheral neuropathy involving GFRα3-expressing neurons
• Nerve growth factor relationships: GFRα3 signaling may interact with NGF and other neurotrophin systems affected in AD

Parkinson's Disease

• Sensory symptoms: Non-motor symptoms in PD include sensory dysfunction that may involve GFRα3 pathways
• Autonomic neuropathy: PD patients often develop autonomic neuropathy affecting peripheral sensory neurons

Amyotrophic Lateral Sclerosis

• Motor neuron involvement: While primarily affecting motor neurons, ALS also involves sensory neuron dysfunction
• GFRα3 potential: May play roles in maintaining sensory neuron function in ALS

Cancer

GFRα3 expression has been detected in various cancers:

• Pancreatic cancer: Overexpression associated with poorer prognosis
• Breast cancer: Some triple-negative breast cancers express GFRα3
• Lung cancer: May contribute to tumor progression
• Therapeutic target: GFRα3 may represent a novel therapeutic target in certain cancers

Therapeutic Targeting

Recombinant Artemin Therapy

• Artemin (ARTN): Recombinant human artemin has been investigated for peripheral neuropathy
• Clinical trials: Evaluated in diabetic neuropathy and CIPN
• Administration: Typically delivered via subcutaneous injection

Small Molecule Agonists

• GFRα3-selective agonists: Being developed for enhanced specificity
• RET agonists: Activate the GFRα3/RET complex

Potential Applications

• Chemotherapy-induced neuropathy prevention
• Diabetic neuropathy treatment
• Chronic pain management
• Peripheral nerve injury recovery

Interaction Network

GFRα3 interacts with multiple proteins and signaling molecules:

• RET (Rearranged during Transfection): Primary co-receptor for signaling
• Artemin (ARTN) - Primary ligand
• NCAM (Neural Cell Adhesion Molecule) - Alternative signaling partner
• GPI-anchored proteins - Membrane microdomain organization
• Src family kinases - For RET-independent signaling
• PI3K p85 subunit - Downstream signaling
• Grb2, Shc - Adapter proteins for MAPK pathway

Animal Models

• Gfra3 knockout mice: Exhibit deficits in sensory and sympathetic neuron development
• Artemin knockout mice: Similar phenotype to Gfra3 knockouts
• Transgenic overexpression models: Used to study gain-of-function effects
• Conditional knockouts: Region-specific deletion studies

Research Methods

• Biochemistry: Protein expression, purification, and binding assays
• Cell biology: Cell survival, neurite outgrowth assays
• Mouse models: Genetic knockouts, behavioral analysis
• Histology: Immunohistochemistry for tissue localization
• Electrophysiology: Sensory neuron function testing

Background

The study of Gfrα3 Protein Gdnf Family Receptor Alpha 3 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
• [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
• [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data

See Also

• [Proteins Index](/proteins)
• [Genes Index](/genes)
• GFRA3 Gene
• [Artemin Protein](/proteins/artemin-protein)
• GDNF Family Signaling
• GDNF Receptor Alpha Family
• Peripheral Neuropathy
• Pain Modulation
• [Neurotrophic Factors](/therapeutics/neurotrophic-factor-therapies) RET Receptor

References